Genentech Says FDA Approves Herceptin Hylecta for Some Breast Cancer Patients

Date : 02/28/2019 @ 5:28PM
Source : Dow Jones News
Stock : Roche Holding (QX) (RHHBY)
Quote : 37.24  -0.36 (-0.96%) @ 4:15PM

Genentech Says FDA Approves Herceptin Hylecta for Some Breast Cancer Patients

Halozyme Therapeutics (NASDAQ:HALO)
Historical Stock Chart

1 Year : From Nov 2018 to Nov 2019

Click Here for more Halozyme Therapeutics Charts.
   By Stephen Nakrosis 

Genentech on Thursday said the U.S. Food and Drug Administration approved Herceptin Hylecta to treat certain patients with breast cancer.

The new approval allows the subcutaneous injection of Herceptin Hylecta in certain patients, either in combination with chemotherapy drugs or alone in people who have received one or more chemotherapy regimens for metastatic disease.

Herceptin Hylecta is a ready-to-use formulation that can be administered in two minutes to five minutes, compared to 30 minutes to 90 minutes for intravenous Herceptin, the company said.

The FDA approval is based on results from three clinical studies in Human Epidermal growth factor Receptor 2-positive early breast cancer, the company said.

Biotech company Halozyme Therapeutics Inc. (HALO) said Herceptin Hylecta is the third product co-formulated with that company's Enhanze drug-delivery technology to receive FDA approval.

Genentech is a member of the Roche Group.


Write to Stephen Nakrosis at


(END) Dow Jones Newswires

February 28, 2019 12:13 ET (17:13 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest RHHBY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.